Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Post An Enquiry

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Chirogate is a professional Prostaglandin manufacturer.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    Skyepharma, an Expert and Innovative CDMO Partner for tailor-made solutions in complex oral solids and bioproduction.

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-06-30

    Virtual Booth

    An Enquiry

    Menu

    Shanghai Minbiotech

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    Key Products KEY PRODUCTS

    EXCIPIENTS

    EXCIPIENTS BY INGREDIENTS

    EXCIPIENTS BY APPLICATIONS

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 1Shanghai Minbiotech

    02 1ChemExpress

    03 1AR Life Sciences

    04 1Porton Pharma Solutions

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    ListList of Suppliers
    Contact SupplierContact Supplier
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
      • fda
      • EDQM
      • WHO-GMP
      Virtual BoothShanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.
      Contact Supplier Contact Supplier
      Flag China
      Virtual Booth Virtual Booth
      Digital Content Digital Content

      2-((3bS,4aR)-5,5-Difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrah...

      Portfolio PDF

      Product Web Link

      Virtual Booth

      Digital Content

      Website

      Corporate PDF

      1620056-83-8
      Lenacapavir
      ​Headquartered in Fengxian District, Shanghai Minbiotech Co., Ltd. is a company specializing in th...
      ​Headquartered in Fengxian District, Shanghai Minbiotech Co., Ltd. is a company specializing in the R&D and production of advanced pharmaceutical intermediates and biological APIs. There are more than 1000 square meters of R&D centers in Nantong, Jiangsu and Jinan, Shandong, with more than 13,000㎡ of production sites. While supplying products to customers, the company also provides services such as technology development, technology transfer and technology exchange, aiming to provide customers with comprehensive supply and solutions in the biomedical industry.
      Shanghai Minbiotech CB

      01

      2-((3bS,4aR)-5,5-Difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrahydro-1H-cyclopropa[3,4]cyclopenta[1,2-c]pyrazol-1-yl)acetic acid

      China
      AGGSpend
      Not Confirmed
      arrow
      • fda
      • EDQM
      • WHO-GMP
      Virtual BoothShanghai Minbiotech is the leading producer of biopharmaceuticals and a variety of high-end generic & innovative drugs.

      Shanghai Minbiotech

      2-((3bS,4aR)-5,5-Difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrah...

      CAS Number : 1620056-83-8

      End Use API : Lenacapavir

      About the Company : ​Headquartered in Fengxian District, Shanghai Minbiotech Co., Ltd. is a company specializing in the R&D and production...

      Shanghai Minbiotech CB

      Intermediate Web Link

      Market Place

      Contact Supplier
        • fda
        • EDQM
        • WHO-GMP
        Virtual BoothChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & novel modalities with ICH-grade quality.
        Contact Supplier Contact Supplier
        Flag China
        Virtual Booth Virtual Booth
        Digital Content Digital Content

        1620056-83-8

        Intermediate Web Link

        Market Place

        1620056-83-8
        Lenacapavir
        ChemExpress is a leading CRO and CDMO partner supporting pharmaceutical and biotech companies worldw...
        ChemExpress is a leading CRO and CDMO partner supporting pharmaceutical and biotech companies worldwide. We specialize in small molecules, biologics, and next-gen modalities including ADCs/XDCs, peptides, and PROTACs. Our comprehensive platform spans drug discovery, process development, and commercial manufacturing, offering quality regulatory starting materials, novel building blocks, intermediates, reference compounds, APIs, and finished drug products. With 19+ years of experience, we’ve built a robust QC/QA system aligned with ICH guidelines to ensure quality across the development lifecycle.
        Company Banner

        02

        1620056-83-8

        China
        CPhI Korea
        Booth #L23
        arrow
        • fda
        • EDQM
        • WHO-GMP
        Virtual BoothChemExpress delivers end-to-end CRO & CDMO solutions for small molecules, biologics & novel modalities with ICH-grade quality.

        ChemExpress

        1620056-83-8

        CAS Number : 1620056-83-8

        End Use API : Lenacapavir

        About the Company : ChemExpress is a leading CRO and CDMO partner supporting pharmaceutical and biotech companies worldwide. We specialize i...

        Company Banner

        Intermediate Web Link

        Market Place

        Contact Supplier
          • fda
          • EDQM
          • WHO-GMP
          Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
          Contact Supplier Contact Supplier
          Flag China
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          2-((3bS,4aR)-5,5-difluoro-3-(trifluoromethyl)-3b,4,4a,5-tetrah...

          Intermediate Web Link

          Market Place

          1620056-83-8
          Lenacapavir
          We are into manufacturing of bulk drug Intermediates and Active Pharmaceutical Ingredients (API). Ou...
          We are into manufacturing of bulk drug Intermediates and Active Pharmaceutical Ingredients (API). Our core competence is contract manufacturing for our clients who are looking for manufacturers committed to quality and delivery with focus on cost reduction of products. We have recently developed many intermediates and APIs in-house to cater to existing and new customers. Our commitment to quality and customer delight has been a key strength contributing to our growth and success. Our research and development division constantly strives to improve existing processes for cost reduction, develop new intermediates etc.
          blank

          03

          Contact Supplier
          • FDA
          • EDQM
          • fda
          • EDQM
          • WHO-GMP
          Virtual Booth Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
          Contact Supplier Contact Supplier
          Flag China
          Virtual Booth Virtual Booth
          Digital Content Digital Content

          2-((3bS,4aR)-5,5-difluoro-3- (trifluoromethyl)-3b,4,4a,5- tetr...

          Intermediate Web Link

          Market Place

          1620056-83-8
          Lenacapavir
          Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in S...
          Porton Pharma Solutions Ltd. was founded in 2005, & the company's stock was successfully listed in Shenzhen Stock Exchange in 2014. Our R&D, manufacturing & operation facilities are located in China, Slovenia, the US, Belgium, Switzerland, Denmark, with more than 6000 employees worldwide. Porton leads the way with its excellent CDMO services, but also supplies APIs & intermediates for the treatment of critical diseases such as HIV/AIDS, diabetes, cancer, & influenza. Our Process Technology Centers & WHO/USFDA/EMA/PDMA/NMPA-inspected Facilities feature state-of-the-art equipment, highly flexible cGMP-compliant production assets.
          blank

          04